Quantitative NMR Study of Insulin-Degrading Enzyme Using Amyloid-β and HIV-1 p6 Elucidates Its Chaperone Activity.
Journal
Biochemistry
ISSN: 1520-4995
Titre abrégé: Biochemistry
Pays: United States
ID NLM: 0370623
Informations de publication
Date de publication:
24 08 2021
24 08 2021
Historique:
pubmed:
4
8
2021
medline:
20
11
2021
entrez:
3
8
2021
Statut:
ppublish
Résumé
Insulin-degrading enzyme (IDE) hydrolyzes monomeric polypeptides, including amyloid-β (Aβ) and HIV-1 p6. It also acts as a nonproteolytic chaperone to prevent Aβ polymerization. Here we compare interactions of Aβ and non-amyloidogenic p6 with IDE. Although both exhibited similar proteolysis rates, the binding kinetics to an inactive IDE characterized using relaxation-based NMR were remarkably different. IDE and Aβ formed a sparsely populated complex with a lifetime of milliseconds in which a short hydrophobic cleavage segment of Aβ was anchored to IDE. Strikingly, a second and more stable complex was significantly populated with a subsecond lifetime owing to multiple intermolecular contacts between Aβ and IDE. By selectively sequestering Aβ in this nonproductive complex, IDE likely increases the critical concentration required for fibrillization. In contrast, IDE and p6 formed a transient, submillisecond complex involving a single anchoring p6 motif. Modulation of intermolecular interactions, thus, allows IDE to differentiate between non-amyloidogenic and amyloidogenic substrates.
Identifiants
pubmed: 34342986
doi: 10.1021/acs.biochem.1c00342
pmc: PMC8895387
mid: NIHMS1777601
doi:
Substances chimiques
Amyloid beta-Peptides
0
Molecular Chaperones
0
Protein Aggregates
0
gag Gene Products, Human Immunodeficiency Virus
0
p6 gag protein, Human immunodeficiency virus 1
0
Insulysin
EC 3.4.24.56
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2519-2523Subventions
Organisme : NIAID NIH HHS
ID : P30 AI036214
Pays : United States
Organisme : NIAID NIH HHS
ID : U54 AI150472
Pays : United States
Organisme : Intramural NIH HHS
ID : Z01 DK033007
Pays : United States
Références
Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13827-32
pubmed: 23922390
Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):11361-6
pubmed: 23798407
PLoS One. 2013 Apr 11;8(4):e59113
pubmed: 23593132
Prion. 2008 Apr-Jun;2(2):51-6
pubmed: 19098445
J Am Chem Soc. 2002 Oct 16;124(41):12352-60
pubmed: 12371879
J Biol Chem. 2013 Jan 25;288(4):2281-9
pubmed: 23188819
J Magn Reson. 2014 Apr;241:3-17
pubmed: 24656076
Crit Rev Biochem Mol Biol. 2017 Oct;52(5):554-582
pubmed: 28635330
N Engl J Med. 2012 Aug 30;367(9):795-804
pubmed: 22784036
Curr Opin Neurobiol. 2004 Oct;14(5):582-8
pubmed: 15464891
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):E11924-E11932
pubmed: 30509980
Nature. 2011 Oct 30;480(7376):268-72
pubmed: 22037310
Trends Pharmacol Sci. 2018 Jan;39(1):49-58
pubmed: 29132916
J Neurosci. 2000 Dec 1;20(23):8745-9
pubmed: 11102481
J Mol Biol. 2010 Jan 15;395(2):430-43
pubmed: 19896952
J Biol Chem. 1993 Oct 15;268(29):21538-44
pubmed: 8104941
J Biol Chem. 2008 Jun 20;283(25):17039-48
pubmed: 18411275
J Biomol NMR. 2019 Sep;73(8-9):461-469
pubmed: 31407202
PLoS One. 2017 Apr 7;12(4):e0174254
pubmed: 28388673
Trends Endocrinol Metab. 2016 Jan;27(1):24-34
pubmed: 26651592